CLINICAL_TRIALS
trial_result
· 2017-12-07
Clinical Trial Update: Corpus Luteum and Uterine Artery Doppler With Serum P and CA125 in Threatened Abortion
Summary
A completed clinical trial evaluating corpus luteum assessment, uterine artery Doppler, and serum progesterone and CA-125 levels in threatened abortion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Nesreen Abdel Fattah Abdullah Shehata | Conditions: Threatened Abortion | Status: COMPLETED